My Fund Comparison
Initilizing list...
|
Tekla Healthcare Opportunities Fund as of
01/21/2020
| NYSE /
THQ |
Asset Class:
Sector Equity Funds
|
1 YR Lipper Avg:
17.06% |
| Growth of $10K |
|
| Avg Annual Total Return % |
| |
10 YR |
5 YR |
1 YR |
YTD |
| Market Return |
-- |
7.31% |
19.22% |
1.74% |
| Lipper Pct. Rank |
-- |
50 |
54 |
50 |
|
| NAV Return |
-- |
7.06% |
17.27% |
2.26% |
| Lipper Pct. Rank |
-- |
47 |
40 |
27 |
| Premium/Discount History |
|
| Premium/Discount |
| 10 YR Avg |
5 YR Avg |
YTD Avg |
|
-- |
-9.110% |
-9.220% |
|
| NAV |
$21.27 |
Market Price |
$19.29 |
| Net Change |
-$0.11 |
Market Change |
-$0.01 |
| Premium/Discount |
-9.31% |
| 1 YR NAV Return |
17.272% |
| 1 YR NAV Rank |
40 |
| 12-Mo Yield as of
12/31/2019 |
Yield
Def |
| Income Only Yield |
0.39% |
| Distribution Yield (Market) |
6.79% |
| Most Recent Income Dividend |
$0.013 |
| Ex-Div Date |
12/19/2019 |
| Most Recent Cap Gain Dividend |
$0.044 |
| Ex-Div Date |
12/19/2019 |
| Dividend Frequency |
Monthly |
| YTD Dividends |
$1.250 |
| YTD Capital Gains |
$0.044 |
| Inception Date |
7/31/2014 |
| Fund Advisor |
Tekla Capital Management LLC |
| Manager & Tenure |
Team Managed |
| Phone |
800-426-5523 |
| Website |
www.teklacap.com |
| Total Net Assets (mil)
as of
12/31/2019 |
$865.9 |
| % Leveraged Assets
as of
9/30/2019 |
22.45% |
| Portfolio Turnover |
56.00% |
| Mgmt Fees |
1.289% |
| Expense Ratio |
2.420% |
| Fund Objective |
| The Fund seeks current income and long-term capital appreciation. Under normal market conditions, the Trust expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industry including equity securities, debt securities, and pooled investment vehicles. |
|
| Top Holdings
(as of 9/30/2019) |
|
Johnson & Johnson ORD |
7.98% |
|
Merck & Co Inc ORD |
7.43% |
|
Pfizer Inc ORD |
5.89% |
|
UnitedHealth Group Inc ORD |
5.72% |
|
Amgen Inc ORD |
3.11% |
|
Abbvie Inc ORD |
3.07% |
|
Medtronic PLC ORD |
2.86% |
|
Bristol-Myers Squibb Co ORD |
2.78% |
|
Celgene Corp ORD |
2.60% |
|
Gilead Sciences Inc ORD |
2.58% |
|
| Top Sectors
(as of 9/30/2019) |
|
Health Care |
84.52% |
|
Financials |
7.09% |
|
Consumer Services |
4.86% |
|
Industrials |
2.06% |
|
Non Classified Equity |
1.74% |
|
|
Resources
Aberdeen Closed-End TV
Asset TV — CEF Channel
CEF Connect
Cohen & Steers CEFs Knowledge Center
Harvest — CEFA Channel
Legg Mason CEFs
Seeking Alpha — CEFA Channel
|
|
Powered by a SySys® data & content management system.
© Thomson Reuters 2019. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|